| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $25.2M | +65.0% |
| SG&A Expense | $13.5M | +36.9% |
| Operating Income | -$41.4M | -69.6% |
| Pre-tax Income | -$39.0M | -62.0% |
| Net Income | -$39.0M | -62.0% |
| EPS (Basic) | -$2.36 | +17.8% |
| EPS (Diluted) | -$2.36 | +17.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $169.7M | +1062.0% |
| Current Assets | $171.4M | +995.1% |
| Total Assets | $180.7M | +581.9% |
| Current Liabilities | $11.5M | +57.3% |
| Total Liabilities | $23.2M | +43.6% |
| Stockholders' Equity | $157.5M | +1422.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$24.9M | -20.0% |
| Capital Expenditures | $0 | -100.0% |
| Investing Cash Flow | $0 | +100.0% |
| Financing Cash Flow | $180.0M | +1177.5% |
| Free Cash Flow | -$24.9M | -19.9% |